Estrogen, hormonal replacement therapy and cardiovascular di... : Current Opinion in
Nephrology and Hypertension Estrogen, hormonal replacement therapy and cardiovascular …

Cardiovascular disease is the leading cause of death in women and claims the lives of more
than half a million women every year. Hypertension is one of the most prevalent and …

Cardiovascular disease is the major cause of death among both men and women in
developed countries. Coronary artery disease, the single most important component of …

Epidemiological studies have shown that cardiovascular disease (CVD) is less common in
pre-menopausal women (Pre-MW) compared to men of the same age or post-menopausal …

Cardiovascular disease remains a major cause of mortality among postmenopausal women.
After menopause, atherogenesis is promoted by a number of metabolic and vascular …

Reports have correlated the use of estrogen for the treatment of menopausal symptoms with
beneficial effects on the cardiovascular system. Molecular, biochemical, preclinical, and …

Cardiovascular disease is very common in women. It is still under diagnosed and under
treated. Many women are not having their risk factors for cardiovascular disease properly …

Background Most epidemiologic studies of cardiovascular disease in postmenopausal
women suggest that estrogen-replacement therapy has a protective effect. The effects of the …

Observational studies in humans and experimental studies in animals and isolated cells
supported the widely held belief that hormone replacement therapy protects the …

The incidence of cardiovascular diseases (CVDs) increases after menopause and at any
age postmenopausal women have a significantly higher incidence of CVD compared to …